Carregant...
Toward rapamycin analog (rapalog)-based precision cancer therapy
Rapamycin and its analogs (rapalogs) are the first generation of mTOR inhibitors, which have the same molecular scaffold, but different physiochemical properties. Rapalogs are being tested in a wide spectrum of human tumors as both monotherapy and a component of combination therapy. Among them, tems...
Guardat en:
| Publicat a: | Acta Pharmacol Sin |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648176/ https://ncbi.nlm.nih.gov/pubmed/26299952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2015.68 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|